Literature DB >> 2537845

Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome.

C D Malchoff1, J Rosa, C R DeBold, R A Kozol, G R Ramsby, D L Page, D M Malchoff, D N Orth.   

Abstract

Inappropriate ACTH secretion with bilateral diffuse or macronodular adrenal hyperplasia is the most common cause of Cushing's syndrome. This report describes a patient with Cushing's syndrome and feminization due to ACTH-independent bilateral macronodular adrenal hyperplasia. A 47-yr-old black man presented with Cushingoid features, diabetes mellitus, hypertension, impotence, and gynecomastia. Urinary cortisol and 17-hydroxycorticosteroid excretion were 94 nmol/mmol creatinine (normal, less than 32) and 5.8 mumol/mmol creatinine (normal, 0.6-3.6), respectively. Both decreased by less than 30% after administration of dexamethasone (8 and 16 mg/day), and urinary 17-hydroxycorticosteroid excretion did not increase after metyrapone (750 mg, orally, every 4 h for six doses). Plasma ACTH was undetectable (less than 1 pmol/L) and was not stimulated by administration of metyrapone or ovine CRH. Serum testosterone was 5.2 nmol/L (normal, 7-30), FSH was 5 U/L (normal, 3-18), LH was 2.8 U/L (normal, 1.5-9.2), and estrone was 767 pmol/L (normal, 55-240). Both adrenal glands were enlarged, with a total weight of 86 g (normal, 8-10), and contained multiple nodules (diameter, greater than 0.5 cm) composed of two active cell types, one of which was also observed between the nodules. Cushing's syndrome with feminization due to ACTH-independent bilateral macronodular adrenal hyperplasia is an unusual process of unknown etiology that should be included with the other known causes of Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537845     DOI: 10.1210/jcem-68-4-855

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies.

Authors:  M A Magiakou; G P Chrousos
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

2.  Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.

Authors:  M Terzolo; A Boccuzzi; A Ali; E Bollito; C De Risi; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

Review 3.  How the new tools to analyze the human genome are opening new perspectives: the use of gene expression in investigations of the adrenal cortex.

Authors:  C A Stratakis; A Horvath
Journal:  Ann Endocrinol (Paris)       Date:  2008-04-18       Impact factor: 2.478

4.  ACTH independent Cushing's disease.

Authors:  J Lindholm; L Christensen; M H Therkildsen
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

5.  Cushing's syndrome due to autonomous macronodular adrenal hyperplasia: long-term follow-up after unilateral adrenalectomy.

Authors:  M Boronat; T Lucas; B Barceló; C Alameda; H Hotait; J Estrada
Journal:  Postgrad Med J       Date:  1996-10       Impact factor: 2.401

6.  Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.

Authors:  Y Nakamura; Y Son; Y Kohno; D Shimono; N Kuwamura; H Koshiyama; H Sasano; T Matsuda
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

7.  Adrenal macrotumors diagnosed by computed tomography.

Authors:  J M López; C Fardella; E Arteaga; P Michaud; J A Rodriguez; F Cruz
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

8.  Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents.

Authors:  M Tarle
Journal:  Urol Res       Date:  1991

9.  [Cushing's syndrome with bilateral nodular adrenal enlargement].

Authors:  M op den Winkel; C J Auernhammer; K W Jauch; G Assmann; C Dietz; K G Parhofer
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

Review 10.  Gynecomastia and hypertension.

Authors:  L Michael Prisant; Edward Chin
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.